Lineage Cell Therapeutics
LCTX
#8829
Rank
C$0.15 B
Marketcap
$0.71
Share price
-0.62%
Change (1 day)
-49.82%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2024 (TTM): -C$30.68 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are C$8.71 Million. In 2023 the company made an earning of -C$35.43 Million a decrease over its 2022 earnings that were of -C$32.26 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$30.68 Million-13.4%
2023 -C$35.43 Million9.83%
2022 -C$32.26 Million-54.24%
2021 -C$70.5 Million86.07%
2020 -C$37.89 Million-31.97%
2019 -C$55.69 Million-5.42%
2018 -C$58.88 Million1.1%
2017 -C$58.24 Million-31.06%
2016 -C$84.47 Million-10.38%
2015 -C$94.26 Million29.69%
2014 -C$72.69 Million31.68%
2013 -C$55.2 Million
2011 -C$26.79 Million89.78%
2010 -C$14.12 Million206.06%
2009 -C$4.62 Million-0.58%
2008 -C$4.64 Million164.89%
2007 -C$1.76 Million-30.22%
2006 -C$2.51 Million
2002 -C$2.92 Million-41.04%
2001 -C$4.95 Million-32.04%
2000 -C$7.28 Million-11.85%
1999 -C$8.26 Million
1997 -C$5.3 Million12.12%
1996 -C$4.73 Million106.25%
1995 -C$2.3 Million-11.11%
1994 -C$2.58 Million50%
1993 -C$1.72 Million20%
1992 -C$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$0.2 Billion 492.84%๐Ÿ‡บ๐Ÿ‡ธ USA